IgGenix Doses First Patient In Peanut Allergy Trial
16 Oct 2024 //
PR NEWSWIRE
IgGenix Presents Data On IGNX001 For Peanut Allergy At ASCIA 2024
02 Sep 2024 //
PR NEWSWIRE
IgGenix`s IGNX001 Shows Peanut Allergy Potential Ahead Of Clinical Trial
03 Jun 2024 //
PR NEWSWIRE
IgGenix Announces Patent Granted Covering Allergen-specific Antibodies
04 Apr 2023 //
BUSINESSWIRE
IgGenix Demonstrated Potential for Single-Cell RNA-Sequencing
02 Mar 2023 //
BUSINESSWIRE